COVID-19 Impact on Global Theraputic Drug Monitorings Market Size, Status and Forecast 2020-2026

COVID-19 Impact on Global Theraputic Drug Monitorings Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Theraputic Drug Monitorings Revenue
1.4 Market Analysis by Type
1.4.1 Global Theraputic Drug Monitorings Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemiluminescence Immunoassay (CLIA)
1.4.3 Fluorescence Immunoassay (FPIA)
1.4.4 Radioimmunoassay (RIA)
1.4.5 Colorimetric Immunoassay
1.4.6 Other Immunoassays
1.5 Market by Application
1.5.1 Global Theraputic Drug Monitorings Market Share by Application: 2020 VS 2026
1.5.2 Antiepileptic Drugs
1.5.3 Immunosuppressant
1.5.4 Antitumor Drugs
1.5.5 Psychotropic Drugs
1.5.6 Antibiotic
1.5.7 Antifungal
1.5.8 Cardiovascular Drugs
1.5.9 Antiasthmatic
1.5.10 Others
1.6 Coronavirus Disease 2019 (Covid-19): Theraputic Drug Monitorings Industry Impact
1.6.1 How the Covid-19 is Affecting the Theraputic Drug Monitorings Industry
1.6.1.1 Theraputic Drug Monitorings Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Theraputic Drug Monitorings Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Theraputic Drug Monitorings Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Theraputic Drug Monitorings Market Perspective (2015-2026)
2.2 Theraputic Drug Monitorings Growth Trends by Regions
2.2.1 Theraputic Drug Monitorings Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Theraputic Drug Monitorings Historic Market Share by Regions (2015-2020)
2.2.3 Theraputic Drug Monitorings Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Theraputic Drug Monitorings Market Growth Strategy
2.3.6 Primary Interviews with Key Theraputic Drug Monitorings Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Theraputic Drug Monitorings Players by Market Size
3.1.1 Global Top Theraputic Drug Monitorings Players by Revenue (2015-2020)
3.1.2 Global Theraputic Drug Monitorings Revenue Market Share by Players (2015-2020)
3.1.3 Global Theraputic Drug Monitorings Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Theraputic Drug Monitorings Market Concentration Ratio
3.2.1 Global Theraputic Drug Monitorings Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Theraputic Drug Monitorings Revenue in 2019
3.3 Theraputic Drug Monitorings Key Players Head office and Area Served
3.4 Key Players Theraputic Drug Monitorings Product Solution and Service
3.5 Date of Enter into Theraputic Drug Monitorings Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Theraputic Drug Monitorings Historic Market Size by Type (2015-2020)
4.2 Global Theraputic Drug Monitorings Forecasted Market Size by Type (2021-2026)
5 Theraputic Drug Monitorings Breakdown Data by Application (2015-2026)
5.1 Global Theraputic Drug Monitorings Market Size by Application (2015-2020)
5.2 Global Theraputic Drug Monitorings Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Theraputic Drug Monitorings Market Size (2015-2020)
6.2 Theraputic Drug Monitorings Key Players in North America (2019-2020)
6.3 North America Theraputic Drug Monitorings Market Size by Type (2015-2020)
6.4 North America Theraputic Drug Monitorings Market Size by Application (2015-2020)
7 Europe
7.1 Europe Theraputic Drug Monitorings Market Size (2015-2020)
7.2 Theraputic Drug Monitorings Key Players in Europe (2019-2020)
7.3 Europe Theraputic Drug Monitorings Market Size by Type (2015-2020)
7.4 Europe Theraputic Drug Monitorings Market Size by Application (2015-2020)
8 China
8.1 China Theraputic Drug Monitorings Market Size (2015-2020)
8.2 Theraputic Drug Monitorings Key Players in China (2019-2020)
8.3 China Theraputic Drug Monitorings Market Size by Type (2015-2020)
8.4 China Theraputic Drug Monitorings Market Size by Application (2015-2020)
9 Japan
9.1 Japan Theraputic Drug Monitorings Market Size (2015-2020)
9.2 Theraputic Drug Monitorings Key Players in Japan (2019-2020)
9.3 Japan Theraputic Drug Monitorings Market Size by Type (2015-2020)
9.4 Japan Theraputic Drug Monitorings Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Theraputic Drug Monitorings Market Size (2015-2020)
10.2 Theraputic Drug Monitorings Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Theraputic Drug Monitorings Market Size by Type (2015-2020)
10.4 Southeast Asia Theraputic Drug Monitorings Market Size by Application (2015-2020)
11 India
11.1 India Theraputic Drug Monitorings Market Size (2015-2020)
11.2 Theraputic Drug Monitorings Key Players in India (2019-2020)
11.3 India Theraputic Drug Monitorings Market Size by Type (2015-2020)
11.4 India Theraputic Drug Monitorings Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Theraputic Drug Monitorings Market Size (2015-2020)
12.2 Theraputic Drug Monitorings Key Players in Central & South America (2019-2020)
12.3 Central & South America Theraputic Drug Monitorings Market Size by Type (2015-2020)
12.4 Central & South America Theraputic Drug Monitorings Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche AG
13.1.1 Roche AG Company Details
13.1.2 Roche AG Business Overview and Its Total Revenue
13.1.3 Roche AG Theraputic Drug Monitorings Introduction
13.1.4 Roche AG Revenue in Theraputic Drug Monitorings Business (2015-2020))
13.1.5 Roche AG Recent Development
13.2 Siemens Healthineers
13.2.1 Siemens Healthineers Company Details
13.2.2 Siemens Healthineers Business Overview and Its Total Revenue
13.2.3 Siemens Healthineers Theraputic Drug Monitorings Introduction
13.2.4 Siemens Healthineers Revenue in Theraputic Drug Monitorings Business (2015-2020)
13.2.5 Siemens Healthineers Recent Development
13.3 Thermo Fisher Scientific
13.3.1 Thermo Fisher Scientific Company Details
13.3.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
13.3.3 Thermo Fisher Scientific Theraputic Drug Monitorings Introduction
13.3.4 Thermo Fisher Scientific Revenue in Theraputic Drug Monitorings Business (2015-2020)
13.3.5 Thermo Fisher Scientific Recent Development
13.4 Beckman Coulter
13.4.1 Beckman Coulter Company Details
13.4.2 Beckman Coulter Business Overview and Its Total Revenue
13.4.3 Beckman Coulter Theraputic Drug Monitorings Introduction
13.4.4 Beckman Coulter Revenue in Theraputic Drug Monitorings Business (2015-2020)
13.4.5 Beckman Coulter Recent Development
13.5 Agilent Technologies
13.5.1 Agilent Technologies Company Details
13.5.2 Agilent Technologies Business Overview and Its Total Revenue
13.5.3 Agilent Technologies Theraputic Drug Monitorings Introduction
13.5.4 Agilent Technologies Revenue in Theraputic Drug Monitorings Business (2015-2020)
13.5.5 Agilent Technologies Recent Development
13.6 BioMérieux
13.6.1 BioMérieux Company Details
13.6.2 BioMérieux Business Overview and Its Total Revenue
13.6.3 BioMérieux Theraputic Drug Monitorings Introduction
13.6.4 BioMérieux Revenue in Theraputic Drug Monitorings Business (2015-2020)
13.6.5 BioMérieux Recent Development
13.7 Sekisui Medical
13.7.1 Sekisui Medical Company Details
13.7.2 Sekisui Medical Business Overview and Its Total Revenue
13.7.3 Sekisui Medical Theraputic Drug Monitorings Introduction
13.7.4 Sekisui Medical Revenue in Theraputic Drug Monitorings Business (2015-2020)
13.7.5 Sekisui Medical Recent Development
13.8 DiaSorin
13.8.1 DiaSorin Company Details
13.8.2 DiaSorin Business Overview and Its Total Revenue
13.8.3 DiaSorin Theraputic Drug Monitorings Introduction
13.8.4 DiaSorin Revenue in Theraputic Drug Monitorings Business (2015-2020)
13.8.5 DiaSorin Recent Development
13.9 Fujirebio
13.9.1 Fujirebio Company Details
13.9.2 Fujirebio Business Overview and Its Total Revenue
13.9.3 Fujirebio Theraputic Drug Monitorings Introduction
13.9.4 Fujirebio Revenue in Theraputic Drug Monitorings Business (2015-2020)
13.9.5 Fujirebio Recent Development
13.10 Grifols
13.10.1 Grifols Company Details
13.10.2 Grifols Business Overview and Its Total Revenue
13.10.3 Grifols Theraputic Drug Monitorings Introduction
13.10.4 Grifols Revenue in Theraputic Drug Monitorings Business (2015-2020)
13.10.5 Grifols Recent Development
13.11 Ortho-Clinical Diagnostics
10.11.1 Ortho-Clinical Diagnostics Company Details
10.11.2 Ortho-Clinical Diagnostics Business Overview and Its Total Revenue
10.11.3 Ortho-Clinical Diagnostics Theraputic Drug Monitorings Introduction
10.11.4 Ortho-Clinical Diagnostics Revenue in Theraputic Drug Monitorings Business (2015-2020)
10.11.5 Ortho-Clinical Diagnostics Recent Development
13.12 Quest Diagnostics
10.12.1 Quest Diagnostics Company Details
10.12.2 Quest Diagnostics Business Overview and Its Total Revenue
10.12.3 Quest Diagnostics Theraputic Drug Monitorings Introduction
10.12.4 Quest Diagnostics Revenue in Theraputic Drug Monitorings Business (2015-2020)
10.12.5 Quest Diagnostics Recent Development
13.13 Sysmex
10.13.1 Sysmex Company Details
10.13.2 Sysmex Business Overview and Its Total Revenue
10.13.3 Sysmex Theraputic Drug Monitorings Introduction
10.13.4 Sysmex Revenue in Theraputic Drug Monitorings Business (2015-2020)
10.13.5 Sysmex Recent Development
13.14 Tosoh
10.14.1 Tosoh Company Details
10.14.2 Tosoh Business Overview and Its Total Revenue
10.14.3 Tosoh Theraputic Drug Monitorings Introduction
10.14.4 Tosoh Revenue in Theraputic Drug Monitorings Business (2015-2020)
10.14.5 Tosoh Recent Development
13.15 Chromsystems
10.15.1 Chromsystems Company Details
10.15.2 Chromsystems Business Overview and Its Total Revenue
10.15.3 Chromsystems Theraputic Drug Monitorings Introduction
10.15.4 Chromsystems Revenue in Theraputic Drug Monitorings Business (2015-2020)
10.15.5 Chromsystems Recent Development
13.16 Bio-Rad
10.16.1 Bio-Rad Company Details
10.16.2 Bio-Rad Business Overview and Its Total Revenue
10.16.3 Bio-Rad Theraputic Drug Monitorings Introduction
10.16.4 Bio-Rad Revenue in Theraputic Drug Monitorings Business (2015-2020)
10.16.5 Bio-Rad Recent Development
13.17 R-Biopharm AG
10.17.1 R-Biopharm AG Company Details
10.17.2 R-Biopharm AG Business Overview and Its Total Revenue
10.17.3 R-Biopharm AG Theraputic Drug Monitorings Introduction
10.17.4 R-Biopharm AG Revenue in Theraputic Drug Monitorings Business (2015-2020)
10.17.5 R-Biopharm AG Recent Development
13.18 ALPCO
10.18.1 ALPCO Company Details
10.18.2 ALPCO Business Overview and Its Total Revenue
10.18.3 ALPCO Theraputic Drug Monitorings Introduction
10.18.4 ALPCO Revenue in Theraputic Drug Monitorings Business (2015-2020)
10.18.5 ALPCO Recent Development
13.19 BIOHIT Healthcare
10.19.1 BIOHIT Healthcare Company Details
10.19.2 BIOHIT Healthcare Business Overview and Its Total Revenue
10.19.3 BIOHIT Healthcare Theraputic Drug Monitorings Introduction
10.19.4 BIOHIT Healthcare Revenue in Theraputic Drug Monitorings Business (2015-2020)
10.19.5 BIOHIT Healthcare Recent Development
13.20 MedTox
10.20.1 MedTox Company Details
10.20.2 MedTox Business Overview and Its Total Revenue
10.20.3 MedTox Theraputic Drug Monitorings Introduction
10.20.4 MedTox Revenue in Theraputic Drug Monitorings Business (2015-2020)
10.20.5 MedTox Recent Development
13.21 Wieslab
10.21.1 Wieslab Company Details
10.21.2 Wieslab Business Overview and Its Total Revenue
10.21.3 Wieslab Theraputic Drug Monitorings Introduction
10.21.4 Wieslab Revenue in Theraputic Drug Monitorings Business (2015-2020)
10.21.5 Wieslab Recent Development
13.22 ARK Diagnostics
10.22.1 ARK Diagnostics Company Details
10.22.2 ARK Diagnostics Business Overview and Its Total Revenue
10.22.3 ARK Diagnostics Theraputic Drug Monitorings Introduction
10.22.4 ARK Diagnostics Revenue in Theraputic Drug Monitorings Business (2015-2020)
10.22.5 ARK Diagnostics Recent Development
13.23 Probe Scientific
10.23.1 Probe Scientific Company Details
10.23.2 Probe Scientific Business Overview and Its Total Revenue
10.23.3 Probe Scientific Theraputic Drug Monitorings Introduction
10.23.4 Probe Scientific Revenue in Theraputic Drug Monitorings Business (2015-2020)
10.23.5 Probe Scientific Recent Development
13.24 Omnica
10.24.1 Omnica Company Details
10.24.2 Omnica Business Overview and Its Total Revenue
10.24.3 Omnica Theraputic Drug Monitorings Introduction
10.24.4 Omnica Revenue in Theraputic Drug Monitorings Business (2015-2020)
10.24.5 Omnica Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Theraputic Drug Monitorings Key Market Segments
Table 2. Key Players Covered: Ranking by Theraputic Drug Monitorings Revenue
Table 3. Ranking of Global Top Theraputic Drug Monitorings Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Theraputic Drug Monitorings Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemiluminescence Immunoassay (CLIA)
Table 6. Key Players of Fluorescence Immunoassay (FPIA)
Table 7. Key Players of Radioimmunoassay (RIA)
Table 8. Key Players of Colorimetric Immunoassay
Table 9. Key Players of Other Immunoassays
Table 10. COVID-19 Impact Global Market: (Four Theraputic Drug Monitorings Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Theraputic Drug Monitorings Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Theraputic Drug Monitorings Players to Combat Covid-19 Impact
Table 15. Global Theraputic Drug Monitorings Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Theraputic Drug Monitorings Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Theraputic Drug Monitorings Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Theraputic Drug Monitorings Market Share by Regions (2015-2020)
Table 19. Global Theraputic Drug Monitorings Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Theraputic Drug Monitorings Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Theraputic Drug Monitorings Market Growth Strategy
Table 25. Main Points Interviewed from Key Theraputic Drug Monitorings Players
Table 26. Global Theraputic Drug Monitorings Revenue by Players (2015-2020) (Million US$)
Table 27. Global Theraputic Drug Monitorings Market Share by Players (2015-2020)
Table 28. Global Top Theraputic Drug Monitorings Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Theraputic Drug Monitorings as of 2019)
Table 29. Global Theraputic Drug Monitorings by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Theraputic Drug Monitorings Product Solution and Service
Table 32. Date of Enter into Theraputic Drug Monitorings Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Theraputic Drug Monitorings Market Size by Type (2015-2020) (Million US$)
Table 35. Global Theraputic Drug Monitorings Market Size Share by Type (2015-2020)
Table 36. Global Theraputic Drug Monitorings Revenue Market Share by Type (2021-2026)
Table 37. Global Theraputic Drug Monitorings Market Size Share by Application (2015-2020)
Table 38. Global Theraputic Drug Monitorings Market Size by Application (2015-2020) (Million US$)
Table 39. Global Theraputic Drug Monitorings Market Size Share by Application (2021-2026)
Table 40. North America Key Players Theraputic Drug Monitorings Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Theraputic Drug Monitorings Market Share (2019-2020)
Table 42. North America Theraputic Drug Monitorings Market Size by Type (2015-2020) (Million US$)
Table 43. North America Theraputic Drug Monitorings Market Share by Type (2015-2020)
Table 44. North America Theraputic Drug Monitorings Market Size by Application (2015-2020) (Million US$)
Table 45. North America Theraputic Drug Monitorings Market Share by Application (2015-2020)
Table 46. Europe Key Players Theraputic Drug Monitorings Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Theraputic Drug Monitorings Market Share (2019-2020)
Table 48. Europe Theraputic Drug Monitorings Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Theraputic Drug Monitorings Market Share by Type (2015-2020)
Table 50. Europe Theraputic Drug Monitorings Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Theraputic Drug Monitorings Market Share by Application (2015-2020)
Table 52. China Key Players Theraputic Drug Monitorings Revenue (2019-2020) (Million US$)
Table 53. China Key Players Theraputic Drug Monitorings Market Share (2019-2020)
Table 54. China Theraputic Drug Monitorings Market Size by Type (2015-2020) (Million US$)
Table 55. China Theraputic Drug Monitorings Market Share by Type (2015-2020)
Table 56. China Theraputic Drug Monitorings Market Size by Application (2015-2020) (Million US$)
Table 57. China Theraputic Drug Monitorings Market Share by Application (2015-2020)
Table 58. Japan Key Players Theraputic Drug Monitorings Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Theraputic Drug Monitorings Market Share (2019-2020)
Table 60. Japan Theraputic Drug Monitorings Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Theraputic Drug Monitorings Market Share by Type (2015-2020)
Table 62. Japan Theraputic Drug Monitorings Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Theraputic Drug Monitorings Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Theraputic Drug Monitorings Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Theraputic Drug Monitorings Market Share (2019-2020)
Table 66. Southeast Asia Theraputic Drug Monitorings Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Theraputic Drug Monitorings Market Share by Type (2015-2020)
Table 68. Southeast Asia Theraputic Drug Monitorings Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Theraputic Drug Monitorings Market Share by Application (2015-2020)
Table 70. India Key Players Theraputic Drug Monitorings Revenue (2019-2020) (Million US$)
Table 71. India Key Players Theraputic Drug Monitorings Market Share (2019-2020)
Table 72. India Theraputic Drug Monitorings Market Size by Type (2015-2020) (Million US$)
Table 73. India Theraputic Drug Monitorings Market Share by Type (2015-2020)
Table 74. India Theraputic Drug Monitorings Market Size by Application (2015-2020) (Million US$)
Table 75. India Theraputic Drug Monitorings Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Theraputic Drug Monitorings Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Theraputic Drug Monitorings Market Share (2019-2020)
Table 78. Central & South America Theraputic Drug Monitorings Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Theraputic Drug Monitorings Market Share by Type (2015-2020)
Table 80. Central & South America Theraputic Drug Monitorings Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Theraputic Drug Monitorings Market Share by Application (2015-2020)
Table 82. Roche AG Company Details
Table 83. Roche AG Business Overview
Table 84. Roche AG Product
Table 85. Roche AG Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 86. Roche AG Recent Development
Table 87. Siemens Healthineers Company Details
Table 88. Siemens Healthineers Business Overview
Table 89. Siemens Healthineers Product
Table 90. Siemens Healthineers Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 91. Siemens Healthineers Recent Development
Table 92. Thermo Fisher Scientific Company Details
Table 93. Thermo Fisher Scientific Business Overview
Table 94. Thermo Fisher Scientific Product
Table 95. Thermo Fisher Scientific Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 96. Thermo Fisher Scientific Recent Development
Table 97. Beckman Coulter Company Details
Table 98. Beckman Coulter Business Overview
Table 99. Beckman Coulter Product
Table 100. Beckman Coulter Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 101. Beckman Coulter Recent Development
Table 102. Agilent Technologies Company Details
Table 103. Agilent Technologies Business Overview
Table 104. Agilent Technologies Product
Table 105. Agilent Technologies Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 106. Agilent Technologies Recent Development
Table 107. BioMérieux Company Details
Table 108. BioMérieux Business Overview
Table 109. BioMérieux Product
Table 110. BioMérieux Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 111. BioMérieux Recent Development
Table 112. Sekisui Medical Company Details
Table 113. Sekisui Medical Business Overview
Table 114. Sekisui Medical Product
Table 115. Sekisui Medical Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 116. Sekisui Medical Recent Development
Table 117. DiaSorin Business Overview
Table 118. DiaSorin Product
Table 119. DiaSorin Company Details
Table 120. DiaSorin Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 121. DiaSorin Recent Development
Table 122. Fujirebio Company Details
Table 123. Fujirebio Business Overview
Table 124. Fujirebio Product
Table 125. Fujirebio Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 126. Fujirebio Recent Development
Table 127. Grifols Company Details
Table 128. Grifols Business Overview
Table 129. Grifols Product
Table 130. Grifols Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 131. Grifols Recent Development
Table 132. Ortho-Clinical Diagnostics Company Details
Table 133. Ortho-Clinical Diagnostics Business Overview
Table 134. Ortho-Clinical Diagnostics Product
Table 135. Ortho-Clinical Diagnostics Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 136. Ortho-Clinical Diagnostics Recent Development
Table 137. Quest Diagnostics Company Details
Table 138. Quest Diagnostics Business Overview
Table 139. Quest Diagnostics Product
Table 140. Quest Diagnostics Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 141. Quest Diagnostics Recent Development
Table 142. Sysmex Company Details
Table 143. Sysmex Business Overview
Table 144. Sysmex Product
Table 145. Sysmex Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 146. Sysmex Recent Development
Table 147. Tosoh Company Details
Table 148. Tosoh Business Overview
Table 149. Tosoh Product
Table 150. Tosoh Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 151. Tosoh Recent Development
Table 152. Chromsystems Company Details
Table 153. Chromsystems Business Overview
Table 154. Chromsystems Product
Table 155. Chromsystems Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 156. Chromsystems Recent Development
Table 157. Bio-Rad Company Details
Table 158. Bio-Rad Business Overview
Table 159. Bio-Rad Product
Table 160. Bio-Rad Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 161. Bio-Rad Recent Development
Table 162. R-Biopharm AG Company Details
Table 163. R-Biopharm AG Business Overview
Table 164. R-Biopharm AG Product
Table 165. R-Biopharm AG Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 166. R-Biopharm AG Recent Development
Table 167. ALPCO Company Details
Table 168. ALPCO Business Overview
Table 169. ALPCO Product
Table 170. ALPCO Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 171. ALPCO Recent Development
Table 172. BIOHIT Healthcare Company Details
Table 173. BIOHIT Healthcare Business Overview
Table 174. BIOHIT Healthcare Product
Table 175. BIOHIT Healthcare Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 176. BIOHIT Healthcare Recent Development
Table 177. MedTox Company Details
Table 178. MedTox Business Overview
Table 179. MedTox Product
Table 180. MedTox Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 181. MedTox Recent Development
Table 182. Wieslab Company Details
Table 183. Wieslab Business Overview
Table 184. Wieslab Product
Table 185. Wieslab Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 186. Wieslab Recent Development
Table 187. ARK Diagnostics Company Details
Table 188. ARK Diagnostics Business Overview
Table 189. ARK Diagnostics Product
Table 190. ARK Diagnostics Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 191. ARK Diagnostics Recent Development
Table 192. Probe Scientific Company Details
Table 193. Probe Scientific Business Overview
Table 194. Probe Scientific Product
Table 195. Probe Scientific Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 196. Probe Scientific Recent Development
Table 197. Omnica Company Details
Table 198. Omnica Business Overview
Table 199. Omnica Product
Table 200. Omnica Revenue in Theraputic Drug Monitorings Business (2015-2020) (Million US$)
Table 201. Omnica Recent Development
Table 202. Research Programs/Design for This Report
Table 203. Key Data Information from Secondary Sources
Table 204. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Theraputic Drug Monitorings Market Share by Type: 2020 VS 2026
Figure 2. Chemiluminescence Immunoassay (CLIA) Features
Figure 3. Fluorescence Immunoassay (FPIA) Features
Figure 4. Radioimmunoassay (RIA) Features
Figure 5. Colorimetric Immunoassay Features
Figure 6. Other Immunoassays Features
Figure 7. Global Theraputic Drug Monitorings Market Share by Application: 2020 VS 2026
Figure 8. Antiepileptic Drugs Case Studies
Figure 9. Immunosuppressant Case Studies
Figure 10. Antitumor Drugs Case Studies
Figure 11. Psychotropic Drugs Case Studies
Figure 12. Antibiotic Case Studies
Figure 13. Antifungal Case Studies
Figure 14. Cardiovascular Drugs Case Studies
Figure 15. Antiasthmatic Case Studies
Figure 16. Others Case Studies
Figure 17. Theraputic Drug Monitorings Report Years Considered
Figure 18. Global Theraputic Drug Monitorings Market Size YoY Growth 2015-2026 (US$ Million)
Figure 19. Global Theraputic Drug Monitorings Market Share by Regions: 2020 VS 2026
Figure 20. Global Theraputic Drug Monitorings Market Share by Regions (2021-2026)
Figure 21. Porter's Five Forces Analysis
Figure 22. Global Theraputic Drug Monitorings Market Share by Players in 2019
Figure 23. Global Top Theraputic Drug Monitorings Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Theraputic Drug Monitorings as of 2019
Figure 24. The Top 10 and 5 Players Market Share by Theraputic Drug Monitorings Revenue in 2019
Figure 25. North America Theraputic Drug Monitorings Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Europe Theraputic Drug Monitorings Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. China Theraputic Drug Monitorings Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Japan Theraputic Drug Monitorings Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Southeast Asia Theraputic Drug Monitorings Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. India Theraputic Drug Monitorings Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Central & South America Theraputic Drug Monitorings Market Size YoY Growth (2015-2020) (Million US$)
Figure 32. Roche AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Roche AG Revenue Growth Rate in Theraputic Drug Monitorings Business (2015-2020)
Figure 34. Siemens Healthineers Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Siemens Healthineers Revenue Growth Rate in Theraputic Drug Monitorings Business (2015-2020)
Figure 36. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Thermo Fisher Scientific Revenue Growth Rate in Theraputic Drug Monitorings Business (2015-2020)
Figure 38. Beckman Coulter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Beckman Coulter Revenue Growth Rate in Theraputic Drug Monitorings Business (2015-2020)
Figure 40. Agilent Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Agilent Technologies Revenue Growth Rate in Theraputic Drug Monitorings Business (2015-2020)
Figure 42. BioMérieux Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. BioMérieux Revenue Growth Rate in Theraputic Drug Monitorings Business (2015-2020)
Figure 44. Sekisui Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Sekisui Medical Revenue Growth Rate in Theraputic Drug Monitorings Business (2015-2020)
Figure 46. DiaSorin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. DiaSorin Revenue Growth Rate in Theraputic Drug Monitorings Business (2015-2020)
Figure 48. Fujirebio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Fujirebio Revenue Growth Rate in Theraputic Drug Monitorings Business (2015-2020)
Figure 50. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Grifols Revenue Growth Rate in Theraputic Drug Monitorings Business (2015-2020)
Figure 52. Ortho-Clinical Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Ortho-Clinical Diagnostics Revenue Growth Rate in Theraputic Drug Monitorings Business (2015-2020)
Figure 54. Quest Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Quest Diagnostics Revenue Growth Rate in Theraputic Drug Monitorings Business (2015-2020)
Figure 56. Sysmex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Sysmex Revenue Growth Rate in Theraputic Drug Monitorings Business (2015-2020)
Figure 58. Tosoh Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Tosoh Revenue Growth Rate in Theraputic Drug Monitorings Business (2015-2020)
Figure 60. Chromsystems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Chromsystems Revenue Growth Rate in Theraputic Drug Monitorings Business (2015-2020)
Figure 62. Bio-Rad Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Bio-Rad Revenue Growth Rate in Theraputic Drug Monitorings Business (2015-2020)
Figure 64. R-Biopharm AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. R-Biopharm AG Revenue Growth Rate in Theraputic Drug Monitorings Business (2015-2020)
Figure 66. ALPCO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. ALPCO Revenue Growth Rate in Theraputic Drug Monitorings Business (2015-2020)
Figure 68. BIOHIT Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. BIOHIT Healthcare Revenue Growth Rate in Theraputic Drug Monitorings Business (2015-2020)
Figure 70. MedTox Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. MedTox Revenue Growth Rate in Theraputic Drug Monitorings Business (2015-2020)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs